Part 7/11:
Research into microdosing faces legal and ethical hurdles, as LSD remains a Schedule I substance in many countries, including the US. However, some researchers are pioneering ways to study these substances responsibly. Dr. David Erritzoe at Imperial College London exemplifies this effort. Instead of traditional clinical trials, his team conducts naturalistic, online surveys where participants report on their own drug use at home.